Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB  SECTOR: Hospital & Healthcare Services

2341.85
+9.75 (0.42%)

Price Summary

Today's High

₹ 2351.35

Today's Low

₹ 2322.1

52 Week High

₹ 2626.3

52 Week Low

₹ 1181.8

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.

Company Essentials

Market Cap

19518.120020245 Cr.

Enterprise Value

18968.926020245 Cr.

No. of Shares

8.3344877 Cr.

P/E

82.46

P/B

17.19

Face Value

₹ 10

Div. Yield

0.51%

Book Value (TTM)

₹  136.1985

CASH

549.194 Cr.

DEBT

0 Cr.

Promoter Holding

55.23%

EPS (TTM)

₹  28.4001

Sales Growth

9.33119523666859%

ROE

23.664573387163 %

ROCE

32.6031769020557 %

Profit Growth

17.523582794571 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1w1m3m6m1Yr3Yr5Yr

* Prices are based on daily market changes.

Valuation Chart 1w1m3m6m1Yr3Yr5Yr

* The chart is based on the standalone earnings of the company.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Sales Growth (in Cr.)

1 Year9.33%
3 Year13.03%
5 Year14.88%

Profit Growth (in Cr.)

1 Year14.19%
3 Year13.54%
5 Year19.45%

ROE%

1 Year23.66%
3 Year24.12%
5 Year26.77%

ROCE %

1 Year32.6%
3 Year34.86%
5 Year39.25%

Debt/Equity

0

Price to Cash Flow

71.76

Interest Cover Ratio

21.6515006821282

CFO/PAT (5 Yr. Avg.)

1.12705897510825

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2020 55.23 0
Sep 2020 55.23 0
Jun 2020 56.32 0
Mar 2020 56.77 0
Dec 2019 56.81 0
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 24.1243126616154% over the past 3 years.
  • Company has been maintaining healthy ROCE of 34.8626631661447% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 21.6515006821282.
  • The Company has been maintaining an effective average operating margins of 25.4961825424876% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -15.2754362056604 days.
  • Company has a healthy liquidity position with current ratio of 4.08158812644054.
  • The company has a good cash flow management; CFO/PAT stands at 1.12705897510825.
  • The company has a high promoter holding of 55.23%.

 Limitations

  • The company has shown a poor revenue growth of 13.0338306322588% for the Past 3 years.
  • The company is trading at a high PE of 82.46.
  • The company is trading at a high EV/EBITDA of 46.9842.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
Net Sales 310.4 287.5 255 404.3 427.1
Total Expenditure 234 231.7 207.7 288.6 296.1
Operating Profit 76.4 55.8 47.3 115.7 131
Other Income 13.3 14 11.1 12.5 14.6
Interest 3.7 3.7 3.5 3.7 3.7
Depreciation 17.4 18.5 16.4 17.7 17.8
Exceptional Items 0 0 0 0 0
Profit Before Tax 68.6 47.6 38.5 106.8 124.1
Tax 17.5 12.3 9.7 26.9 31.4
Profit After Tax 51.1 35.3 28.8 79.9 92.7
Adjusted EPS (Rs) 0.61 0.42 0.35 0.96 1.11

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Net Sales 765.4 881.88 1024.04 1164.9 1273.6
Total Expenditure 563.62 651.76 767.94 882.1 945.79
Operating Profit 201.78 230.11 256.11 282.8 327.81
Other Income 22.47 28.28 31.51 46.49 57.61
Interest 0.49 0.7 0.82 0.74 14.66
Depreciation 32.01 26.44 31.05 36.18 68.01
Exceptional Items 0 0 0 0 0
Profit Before Tax 191.75 231.26 255.76 292.37 302.75
Tax 66 78.78 87.49 96.93 79.57
Net Profit 125.75 152.48 168.27 195.44 223.18
Adjusted EPS (Rs.) 15.21 18.36 20.19 23.45 26.78

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Equity and Liabilities
Share Capital 82.68 83.07 83.33 83.34 83.35
Total Reserves 396.57 503.37 693.19 847.49 932.94
Borrowings 0 0 0 0 0
Other N/C liabilities 12.07 -6 -8.46 -19.86 68.18
Current liabilities 88.96 82.58 111.12 134.46 211.29
Total Liabilities 580.27 663.01 879.18 1045.43 1295.75
Assets
Net Block 129.78 120.99 172.54 172.96 296.53
Capital WIP 4.09 15.33 9.36 2.87 10.3
Investments 11.59 31.32 29.72 32.37 93.88
Loans & Advances 15.21 16.11 14.61 16.24 18.43
Other N/C Assets 3.52 23.4 40.21 24.77 14.2
Current Assets 416.07 455.87 612.76 796.23 862.41
Total Assets 580.27 663.01 879.18 1045.43 1295.75
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Profit Before Tax 191.75 152.48 255.76 292.37 302.75
Adjustment 11.02 90.08 17.3 8.85 45.84
Working Capital Changes 6.22 -7.91 7.86 9.66 12.57
Tax Paid -66.74 -67.99 -91.53 -102.38 -89.17
Operating Cash Flow 142.25 166.67 189.38 208.5 271.99
Investing Cash Flow -148.14 -134.49 -165.9 -92.75 -19.47
Financing Cash Flow 0.99 -31.59 12.93 -54.33 -187.22
Net Cash Flow -4.89 0.59 36.41 61.43 65.3

Corporate Actions

Ratings & Research Reports

Company Presentations

Company News

Dr Lal Pathlabs Stock Price Analysis and Quick Research Report. Is Dr Lal Pathlabs an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Dr Lal Pathlabs and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 271.988 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Dr Lal Pathlabs has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Dr Lal Pathlabs , the EPS growth was 14.1909842601951 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Dr Lal Pathlabs has OPM of 25.7388909216252 % which is a good sign for profitability.
     
  • ROE: Dr Lal Pathlabs have a healthy ROE of 23.664573387163 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Dr Lal Pathlabs

X